• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘按需使用药物的使用模式及患者特征。

As-needed medication use in asthma usage patterns and patient characteristics.

作者信息

Mawhinney H, Spector S L, Heitjan D, Kinsman R A, Dirks J F, Pines I

机构信息

Department of Medicine, UCLA School of Medicine.

出版信息

J Asthma. 1993;30(1):61-71. doi: 10.3109/02770909309066381.

DOI:10.3109/02770909309066381
PMID:8428860
Abstract

Daily inhaled bronchodilator medication usage was recorded using an electronic device and airway obstruction by daily peak flow measurement. The demographic, clinical, and psychological characteristics of the subjects were noted. Subjects were allocated to as-needed (prn) medication usage groups according to the mean number of inhaler activations on days with zero, moderate, and severe airway obstruction. Segregation into arbitrary and nonarbitrary use, and into overuse, appropriate use, and underuse resulted in six usage groups. Appropriate use was observed in only 10 of 39 subjects. The major psychological variable to differ among groups was the MMPI variable Pt, representing general anxiety. Arbitrary users had a significantly higher mean score than nonarbitrary users. The variable Specific Internal Awareness, representing a perceived difficulty in recognizing the premonitory symptoms of an asthma attack, also differed among the usage groups, with arbitrary users having the lowest scores. These findings raise the possibility that reliance on an objective measurement of airway obstruction rather than on subjective symptomatology might enhance compliance with prn medication in some patients.

摘要

使用电子设备记录每日吸入支气管扩张剂的用药情况,并通过每日峰值流量测量来评估气道阻塞情况。记录受试者的人口统计学、临床和心理特征。根据在气道阻塞为零、中度和重度的日子里吸入器激活的平均次数,将受试者分配到按需(prn)用药组。分为随意使用和非随意使用,以及过度使用、适当使用和使用不足,从而形成六个用药组。在39名受试者中,只有10人观察到适当使用。各组之间存在差异的主要心理变量是明尼苏达多相人格调查表(MMPI)中的Pt变量,代表一般焦虑。随意使用者的平均得分显著高于非随意使用者。代表在识别哮喘发作先兆症状方面存在感知困难的特定内部意识变量在各用药组之间也存在差异,随意使用者得分最低。这些发现增加了一种可能性,即对于某些患者而言,依赖气道阻塞的客观测量而非主观症状可能会提高按需用药的依从性。

相似文献

1
As-needed medication use in asthma usage patterns and patient characteristics.哮喘按需使用药物的使用模式及患者特征。
J Asthma. 1993;30(1):61-71. doi: 10.3109/02770909309066381.
2
Nonprescription bronchodilator medication use in asthma.非处方支气管扩张剂药物在哮喘中的应用。
Chest. 1997 Oct;112(4):987-93. doi: 10.1378/chest.112.4.987.
3
The psychological factors associated with poor compliance with treatment in asthma.与哮喘治疗依从性差相关的心理因素。
Eur Respir J. 1995 Jun;8(6):899-904.
4
Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.布地奈德/福莫特罗单吸入器疗法与高剂量布地奈德治疗中重度哮喘的疗效和安全性比较
Curr Med Res Opin. 2004 Sep;20(9):1403-18. doi: 10.1185/030079904X2051.
5
The effect of inhaled albuterol in moderate to severe asthma.吸入用沙丁胺醇对中重度哮喘的疗效。
J Allergy Clin Immunol. 1996 Aug;98(2):295-301. doi: 10.1016/s0091-6749(96)70153-7.
6
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.一项为期12周的多中心、随机、部分盲法、活性药物对照、平行组研究,旨在评估布地奈德吸入混悬液用于此前使用定量气雾剂或干粉吸入器吸入皮质类固醇治疗的中度至重度持续性哮喘青少年和成人患者的疗效。
Clin Ther. 2007 Jun;29(6):1013-26. doi: 10.1016/j.clinthera.2007.06.005.
7
Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study.雾化吸入丙酸氟替卡松,治疗儿童中度哮喘发作时全身用药的可行替代方案:一项双盲、双模拟研究。
Respir Med. 2015 Sep;109(9):1120-5. doi: 10.1016/j.rmed.2015.07.007. Epub 2015 Jul 14.
8
Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.与其他吸入器相比,一种干粉吸入器在治疗开始时的使用情况和可用性:在波兰和德国进行的一项开放性、非干预性观察性研究。
Pneumonol Alergol Pol. 2015;83(5):365-77. doi: 10.5603/PiAP.2015.0059.
9
Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use.在慢性气流阻塞患者和长期家庭雾化器使用患者中,吸入器使用不当非常常见。
Respir Med. 2012 May;106(5):668-76. doi: 10.1016/j.rmed.2011.11.016. Epub 2012 Jan 25.
10
Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.多剂量干粉吸入器吸入福莫特罗一日两次与定量气雾剂吸入沙丁胺醇一日四次对持续性哮喘患者的疗效、耐受性及哮喘相关生活质量的影响:一项多中心、随机、双盲、双模拟、安慰剂对照的平行组研究。
Clin Ther. 2004 Oct;26(10):1587-98. doi: 10.1016/j.clinthera.2004.10.004.

引用本文的文献

1
[Not Available].[无可用内容]
Tunis Med. 2023 Jun 5;101(6):553-558.
2
Discomfort Intolerance in Relation to Asthma Outcomes.与哮喘结局相关的不适不耐受
Cognit Ther Res. 2019 Feb;43(1):24-31. doi: 10.1007/s10608-018-9965-y. Epub 2018 Sep 26.
3
Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal.哮喘的单一维持和缓解治疗(SMART):批判性评价。
Thorax. 2010 Aug;65(8):747-52. doi: 10.1136/thx.2009.128504. Epub 2010 Jun 27.
4
Rationale for once-daily therapy in asthma: compliance issues.哮喘每日一次治疗的基本原理:依从性问题。
Drugs. 1999;58 Suppl 4:1-6; discussion 51. doi: 10.2165/00003495-199958004-00001.